Clinical Trials Directory

Trials / Completed

CompletedNCT02325713

Relative Bioavailability Trial of Oral Dispersible Praziquantel Tablets in Healthy Volunteers

A Phase I, Open-label, Randomized, Four-period, Crossover, Single Center Trial to Assess the Relative Bioavailability of a Single Oral Dose of the New 150 mg Oral Dispersible Tablet (ODT) Formulation of Praziquantel (PZQ), MSC1028703A, at Different Dose Levels vs the Current Commercial 500 mg Tablet Formulation of PZQ in Healthy Male Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Merck KGaA, Darmstadt, Germany · Industry
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This is a phase I, open-label, randomized, 4 period, crossover, single-center trial. The purpose of this trial is to assess the relative bio-availability of racemate Oral Dispersible Tablet praziquantel (ODT-PQZ) (MSC1028703A) 150 milligram (mg) versus the current marketed praziquantel (PZQ) (Cysticide® 500 mg) formulation in healthy male volunteers.

Conditions

Interventions

TypeNameDescription
DRUGOral dispersible tablet of praziquantel (ODT-PZQ)Treatment A (test): ODT-PZQ (MSC1028703A) at a single dose of 40 milligram per kilogram (mg/kg) orally dispersed in water after meal.
DRUGCysticideTreatment B (reference): Cysticide tablet at a single dose of 40 mg/kg will be given with water orally after a meal.
DRUGODT-PZQTreatment C1 (test): ODT-PZQ (MSC1028703A) at a single dose of 20 mg/kg orally dispersed in water after a meal.
DRUGODT-PZQTreatment C2 (test): ODT-PZQ (MSC1028703A) at a single dose of 60 mg/kg orally dispersed in water after a meal.
DRUGODT-PZQTreatment D1 (test): ODT-PZQ (MSC1028703A) at a single dose of 40 mg/kg orally dispersed in water without a meal.
DRUGCysticideTreatment D2 (reference): Cysticide crushed tablets at a single dose of 40 mg/kg will be given with water orally after a meal.

Timeline

Start date
2015-01-01
Primary completion
2015-01-01
Completion
2015-03-01
First posted
2014-12-25
Last updated
2017-02-23
Results posted
2017-02-23

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02325713. Inclusion in this directory is not an endorsement.